𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of HeLa cells spreading by the non-receptor tyrosine kinase ACK-2

✍ Scribed by Melissa Coon; Roman Herrera


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
404 KB
Volume
84
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The CDC42 regulated non‐receptor tyrosine kinase ACK‐2 has been associated with integrin signaling. In this report, the effect of ACK‐2 on the modulation of cell spreading and motility was examined. HeLa cells expressing epitope‐tagged wild type ACK‐2 showed a slower rate of spreading on fibronectin when compared with untransfected cells. An ACK‐2 protein lacking its SH3 domain was still capable of modulating HeLa cell spreading suggesting that its tyrosine kinase activity is sufficient to induce the observed phenotype. The ACK‐2 effect on the rate of cell spreading did not involve inhibition of integrin‐mediated activation of PI‐3K signaling, since it did not alter membrane translocation of a GFP‐PH‐AKT domain (AKT pleckstrin homology domain) used as a reporter for PI‐3K products induced by cell adhesion. The ACK‐2 effect appears to be upstream from the adapter protein CrkII, since co‐expression of CrkII and ACK‐2 results in a neutralization of ACK‐2 mediated effects on HeLa cell spreading. Similarly, co‐expression of p130Cas, which interacts with the adapter protein CrkII, with ACK‐2, also results in a partial reversion of the ACK‐2 effects on cell spreading. CrkII mediated reversal of the ACK‐2 induced phenotype requires the activity of the small GTPase, Rap1. Co‐expression of ACK‐2 and CrkII with a dominant negative form of Rap1 reverses the neutralization by CrkII suggesting that CrkII mediated activation of Rap1 is required. However, an active form of Rap1 is not sufficient to reverse the ACK‐2 phenotype by itself. A role for Rac1 in ACK‐2 effects was also established. An activated Rac1 protein neutralized the ACK‐2 mediated inhibition of cell spreading. A direct measurement of cell motility by either a modified Boyden chamber or wounding assay demonstrates that ACK‐2 overexpression increases the motility of the cells. These results suggest that ACK‐2 modulates HeLa cells spreading upstream of pathways regulated by CrkII and that ACK‐2 may regulate cell motility by controlling the activation of small GTPases such as Rap1 and Rac1. J. Cell. Biochem. 84: 655–665, 2002. © 2001 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Regulation of the human bradykinin B2 re
✍ Guadalupe Reyes-Cruz; José Vázquez-Prado; Werner Müller-Esterl; Luis Vaca 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB 👁 2 views

The functional regulation of the human bradykinin B2 receptor expressed in sf21 cells was studied. Human bradykinin B2 receptors were immunodetected as a band of 75-80 kDa in membranes from recombinant baculovirus-infected cells and visualized at the plasma membrane, by confocal microscopy, using an

Targeted inhibition of the epidermal gro
✍ Alessandro Sgambato; Andrea Camerini; Beatrice Faraglia; Raffaele Ardito; Gabrie 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 1 views

## Abstract The epidermal growth factor (EGF) plays a role in the development of prostate cancer, which becomes essential after androgen resistance has emerged. The EGF receptor (EGFR) is therefore a potential target for anticancer therapy. We evaluated the effects of ZD1839 (‘Iressa’), an orally a